Skip to content

Validation of Hand Held Dynamometer for Assessment of Lower Limb Muscle Strength in Multiple Sclerosis

Validation of a Hand-Held Dynamometer for Assessment of Lower Limb Muscle Strength in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01749943
Acronym
HHD
Enrollment
21
Registered
2012-12-17
Start date
2012-07-31
Completion date
2013-07-31
Last updated
2013-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Brief summary

Evaluate a method of testing the strength of five key lower limb muscle groups using a hand-held strength gauge (dynamometer).

Detailed description

Purpose of this study is to assess the intra-rater and inter-rater reliability of a hand-held dynamometer (HHD) in the assessment of lower limb strength in patients with Multiple Sclerosis. Also to establish a standardized strength testing procedure for key lower limb muscle groups using a HHD fo research and clinical purposes in Multiple Sclerosis.

Interventions

None listed

Sponsors

Biogen
CollaboratorINDUSTRY
Brown, Theodore R., M.D., MPH
Lead SponsorINDIV

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Stable patients with clinically definite Multiple Sclerosis * No Multiple Sclerosis exacerbation 30 days prior to screening * No change in disease modifying therapy for 30 day prior to screening

Exclusion criteria

* Inflammatory myopathy * Endocarditis, pericarditis o rother unstable heart disease * Cardiac surgery or myocardial infarction in the last 3 months * Decompensated congestive heart failure * Severe aortic stenosis * Severe pulmonary hypertension * Pulmonary embolus or infarction in the last 6 months * Uncontrolled hypertension by history or by screening or baseline diastolic blood pressure \>170 or systolic blood pressure \>105 * Concomitant neurodegenerative neurological disease such as Amyotrophic Lateral Sclerosis (ALS) Parkinsons or hemiplegic stroke * females who are pregnant * Cognitive deficits that would interfere with the subjects's ability to give informed consent or preform study testing * Painful orthopedic condition affecting the lower limbs * Any other serious and/or unstable medical condition

Design outcomes

Primary

MeasureTime frameDescription
Assessment of HHDOutcome measures will be assessed once we have captured all data points for all 21 subjects.To assess the intra-rater and inter-rater reliability of a hand-held dynamometer(HHD) in the assessment of lower limb strength in patients with Multiple Sclerosis. To establish a standardized strength testing procedure for key lower limb muscle groups using a HHD for research and clinical purposes in Multiple Sclerosis.

Secondary

MeasureTime frameDescription
Validation of a Hand-held dynamometer for assessment of lower limb muscle strength.outcome measures will be assessed once we have captured all data points for all 21 subjectsto establish a standardized strength testing procedure for key lower limb muscle groups using a Hand-held dynamometer for research and clinical purposes in Multiple Sclerosis.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026